Links

Tools

Export citation

Search in Google Scholar

A Survey of Evidence of Restricted Indications Approved for New Drugs

Journal article published in 2006 by 林勇良, 林敏雄, 陳建煒, K. Arnold Chan ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

為了解新藥核准之限制性適應症,以便日復核准新藥之適應症時,得以在特定之需要情況下,限制某種程度病患方得使用,例如輕微、中度或重度乾癬,本研究回顧自1996年7月至2002年7月經美國食品及藥物管理局核准之新藥仿單,將其中具限制性適應症之案例挑出,在這些案例中,仿單及新藥評估報告中臨床試驗之納入條件是否要求受試者必須具備某程度之疾病之資訊,作者逐一整理並分析其類別與疾病,經研究,總共收集到20例被核准限制性適應症之新藥,除一案例因資料不足外,其他案例於臨床試驗中皆要求受試者必須具備某一程度之疾病,且此一疾病嚴重程度與核准之適應症疾病嚴重程度相同。